SMA Program Advances with Additional Product Candidate Entering Clinical Development dne January 10, 2016 PTC Therapeutics RG7800 RG7916 Roche SMA Foundation SMN2 +
PTC Therapeutics Phase 1 Clinical Data on RG7800 dne May 26, 2015 PTC Therapeutics RG7800 Roche SMA Foundation smn protein SMN2 +
Joint Program in SMA Enters First Stage of Clinical Development dne January 23, 2014 PTC Therapeutics Roche SMA Foundation spinal muscular atrophy spinal muscular atrophy cure Spinal Muscular Atrophy Foundation +